Managing Parkinson's disease during surgery.

and delivering lectures for Abbott, Pfizer, MSD, Janssen-Cilag, Leo, and Basilea and does consultancy for Merck and Novartis; MHB is employed by SIGN; JL was paid to attend one Abbott Advisory Board meeting and to deliver postgraduate education by Leo, has received meeting expenses from Pfizer, and has undertaken trials funded by Janssen-Cilag, Merck, Serono, Schering-Plough, Abbott, and Pfizer; HW has been paid to provide expert testimony to the Psoriatic Arthritis Advisory Panel and to develop and deliver a Wyeth educational presentation, and has received expenses from Abbott to attend one conference; HW’s institution will receive payment for participating in a study of the validity of the PEST questionnaire; RR received travel costs and a conference registration fee from Wyeth; ADO was paid to attend one Abbott advisory board meeting, one Schering-Plough advisory board meeting, and to deliver lectures for Wyeth and Abbott, and received expenses to attend one conference from Wyeth and one conference from Janssen-Cilag; ADO’s institution has received grants to conduct clinical trials of biologics for Abbott, Wyeth, Schering-Plough, and Janssen-Cilag; no other relationships or activities that could appear to have influenced the submitted work.